Pancreatic Cancer
📧 Sign up to get email alerts when something new happens for Pancreatic Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-02-18Clinical Trial Update: Exploratory Clinical Study of Claudin18.2-Targeted Activated DC and CAR-T Therapy in Advanced Pancreatic Cancer. [EARLY_Phase 1]
An early-phase exploratory clinical study is evaluating Claudin18.2-targeted Activated Dendritic Cells and Claudin18.2-targeted CAR-T therap…
-
CLINICAL_TRIALS research · 2026-02-18Clinical Trial Update: Endoscopic Ultrasound Radiofrequency Ablation, Database Repository
Ongoing clinical trial update from Indiana University on Endoscopic Ultrasound Radiofrequency Ablation for pancreatic cancer; enrollment is …
-
CLINICAL_TRIALS research · 2026-02-17Clinical Trial Update: A Study of MRG007 (ARR-217) in Patients With Advanced Solid Tumors [Phase 1]
A Phase 1 trial of MRG007 (ARR-217) in patients with advanced solid tumors is recruiting, evaluating safety and initial efficacy signals in …
-
CLINICAL_TRIALS research · 2026-02-17Clinical Trial Update: Anti-Mesothelin TNaive/SCM hYP218 (TNhYP218) CAR T Cells in Participants With Mesothelin-Expressing Solid Tumors Including Mesothelioma [Phase 1]
Phase 1 clinical trial update for TNhYP218 anti-mesothelin CAR T cells in mesothelin-expressing solid tumors, including mesothelioma; recrui…
-
CLINICAL_TRIALS research · 2026-02-17Clinical Trial Update: INTEGRATIVE "MULTI-OMICS" AND FUNCTIONAL PLATFORM FOR THE COMPLETE DIAGNOSTIC CHARACTERIZATION OF TUMORS: THE ITALIAN TUMOR CHEMOGENOMIC PROFILER (IT-TCP) [NA]
A clinical trial update describing the Italian Tumor Chemogenomic Profiler (IT-TCP), an integrative multi-omics and functional platform to d…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2026-02-17Clinical Trial Update: The Effect of Celiac Axis Stenosis on Morbidity After Pancreatoduodenectomy - A Prospective Study
A prospective clinical trial update examining whether celiac axis stenosis influences morbidity after pancreaticoduodenectomy, currently act…
-
CLINICAL_TRIALS research · 2026-02-17Clinical Trial Update: A Phase II Nationwide, Fully Decentralized, Telemedicine Study of Pemigatinib in Adult Patients With Advanced or Metastatic Pancreatic Cancer With FGFR Genetic Alterations [Phase 2]
A Phase II nationwide, fully decentralized telemedicine study of pemigatinib for adults with FGFR-altered advanced or metastatic pancreatic …
-
CLINICAL_TRIALS research · 2026-02-17Clinical Trial Update: Combined Chemotherapy And Ablative Radiotherapy (SBRT) As First-Line Treatment In Locally Advanced Inoperable Pancreatic Cancer (SBRT-PANC) [NA]
Clinical trial NCT07407231 is evaluating combined chemotherapy and ablative radiotherapy (SBRT) as first-line treatment for locally advanced…
-
CLINICAL_TRIALS research · 2026-02-17Clinical Trial Update: Assessment of the Prognosis of Pancreatic Cancer Patients Using 3D MRE
This clinical trial entry indicates a study evaluating whether 3D magnetic resonance elastography can predict prognosis in pancreatic cancer…
-
CLINICAL_TRIALS research · 2026-02-17Clinical Trial Update: Phase 1/2 Dose Finding, Safety and PK Study in Advanced Refractory Solid Tumors [Phase 1, Phase 2]
Phase 1/2 dose-finding study evaluating safety, pharmacokinetics, and dose optimization of a new therapy in advanced refractory solid tumors…
-
CLINICAL_TRIALS research · 2026-02-13Clinical Trial Update: A Study of CLSP-1025 in Adult Patients With Solid Tumors That Harbor the p53 R175H Mutation [Phase 1]
This clinical trial update states that CLSP-1025 is being evaluated in a Phase 1 study for adults with solid tumors harboring the p53 R175H …
-
CLINICAL_TRIALS research · 2026-02-13Clinical Trial Update: XH001 Combination With Immunocheckpoint Inhibitor and Chemotherapy for Patients With Resected Pancreatic Cancer [NA]
A clinical trial update states that XH001 is being studied in combination with an immunocheckpoint inhibitor and chemotherapy for patients w…
-
CLINICAL_TRIALS research · 2026-02-13Clinical Trial Update: Solid Tumor Analysis for HLA Loss of Heterozygosity (LOH) and Apheresis for CAR T- Cell Manufacturing
This ClinicalTrials.gov entry describes a study by A2 Biotherapeutics evaluating HLA LOH analysis and apheresis for CAR-T cell manufacturing…
-
CLINICAL_TRIALS research · 2026-02-13Clinical Trial Update: FOLFIRINOX Versus OncoSil™ in Addition to FOLFIRINOX in Patients With Locally Advanced Pancreatic Adenocarcinoma [Phase 2]
Phase 2 trial comparing FOLFIRINOX with and without OncoSil in locally advanced pancreatic cancer; the study is currently active but not rec…
-
CLINICAL_TRIALS research · 2026-02-13Clinical Trial Update: MRE for Diagnosis of Pancreatic Masses
A clinical trial is currently recruiting to evaluate magnetic resonance elastography for diagnosing pancreatic masses.
-
CLINICAL_TRIALS research · 2026-02-11Clinical Trial Update: Predictive Value of Transcriptome-based OncoTreat/Oncotarget and Organoid Testing in Metastatic Pancreatic Cancer.
This clinical trial investigates whether transcriptome-based OncoTreat/Oncotarget profiling and patient-derived organoid testing can predict…
-
CLINICAL_TRIALS research · 2026-02-11Clinical Trial Update: A Prospective Observational Study of First-Line Systemic Therapy Combined With Celiac Plexus Blockade for Advanced Biliopancreatic Cancer With Pain
An observational study evaluating first-line systemic therapy combined with celiac plexus blockade for pain in advanced biliary tract cancer…
-
CLINICAL_TRIALS research · 2026-02-11Clinical Trial Update: Pancreas Registry and High Risk Registry
Clinical trial registry update for the Pancreas Registry and High Risk Registry, focusing on pancreatic diseases and currently recruiting pa…
-
CLINICAL_TRIALS research · 2026-02-11Clinical Trial Update: A Phase 1 Study to Evaluate Safety and Efficacy of XER-001 (Amifostine for Nasoduodenal Delivery) in Combination With Sterotactic Body Radiotherapy for Treatment in Patients With Locally Advanced Pancreatic Cancer. [Phase 1, Phase 2]
A Phase 1/2 trial to evaluate the safety and efficacy of XER-001 (amifostine delivered nasoduodenally) in combination with stereotactic body…
-
CLINICAL_TRIALS research · 2026-02-11Clinical Trial Update: A Study to Evaluate Safety, Tolerability and Preliminary Activity of AGX101 in Participants With Advanced Solid Tumors [Phase 1]
This is a Phase 1 clinical trial evaluating the safety, tolerability, and preliminary activity of AGX101 in adults with advanced solid tumor…
-
CLINICAL_TRIALS research · 2026-02-10Clinical Trial Update: Efficacy and Safety of Surufatinib Combined With Gemcitabine and Albumin-bound Paclitaxel in the Peri-operative Treatment of Pancreatic Cancer [Phase 2]
This ClinicalTrials.gov entry describes a Phase 2 trial evaluating surufatinib in combination with gemcitabine and nab-paclitaxel as peri-op…
-
CLINICAL_TRIALS research · 2026-02-10Clinical Trial Update: Polymeric Micellar Paclitaxel for Metastatic Pancreatic Cancer [Phase 3]
Phase 3 trial evaluating polymeric micellar paclitaxel for metastatic pancreatic cancer. The study is currently recruiting.
-
CLINICAL_TRIALS research · 2026-02-10Clinical Trial Update: Testing the Use of the Usual Chemotherapy Before and After Surgery for Removable Pancreatic Cancer [Phase 3]
A Phase 3 clinical trial update evaluating the use of standard chemotherapy before and after surgery for resectable pancreatic cancer is cur…
-
CLINICAL_TRIALS research · 2026-02-09Clinical Trial Update: P-MUC1C-ALLO1 Allogeneic CAR-T Cells in the Treatment of Subjects With Advanced or Metastatic Solid Tumors [Phase 1]
Phase 1 trial update of P-MUC1C-ALLO1, an allogeneic CAR-T cell therapy, being studied in advanced or metastatic solid tumors. The study is …
-
CLINICAL_TRIALS research · 2026-02-09Clinical Trial Update: Study of DNA Damage, Angiogenesis, and PD-L1 Inhibitors in Advanced Solid Tumors [Phase 2]
This notice reports a Phase 2 clinical trial evaluating a PD-L1 inhibitor in combination with strategies targeting DNA damage and angiogenes…